Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein

Hepatocellular carcinoma (HCC), an aggressive and the fastest growing life-threatening cancer worldwide, is often diagnosed at intermediate or advanced stages of the disease, which substantially limits therapeutic approaches for its successful treatment. This indicates that the prevention of hepatoc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Ortega, Juliana F., de Conti, Aline, Tryndyak, Volodymyr, Furtado, Kelly S., Heidor, Renato, Horst, Maria Aderuza, Fernandes, Laura Helena Gasparini, Tavares, Paulo Eduardo Latorre Martins, Pogribna, Marta, Shpyleva, Svitlana, Beland, Frederick A., Pogribny, Igor P., Moreno, Fernando Salvador
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029705/
https://ncbi.nlm.nih.gov/pubmed/27013579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8248
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak